spike detection algorithm p13 software Search Results


sars-cov-2 spike protein rbd-coated plates, clear, 96-well  (AMS Biotechnology)
N/A
SARS-CoV-2 Spike protein RBD-Coated Plates, Clear, 96-Well
   Buy from Supplier
ct-p13  (Celltrion inc)
90
Celltrion inc ct-p13
<t>CT-P13</t> quantification of exogenously-spiked samples (μg/ml). The bars indicate the mean concentration obtained with each assay in the different concentrations, and the error bars refer to the standard deviation. IFX, infliximab; QB, Quantum Blue ® Infliximab: Quantitative Lateral Flow Assay (Bühlmann, Schönenbuch, Switzerland).
Ct P13, supplied by Celltrion inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spike+detection+algorithm+p13+software/ct+p13/pmc05598811-79-4-32
Average 90 stars, based on 1 article reviews
ct-p13 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
soluble reactive phosphate spiking solution  (AXIO Proficiency Testing)
N/A
30ml Soluble reactive phosphate spiking solution
   Buy from Supplier
sars cov 2 spike protein rbd coated plates  (ACROBiosystems)
N/A
   Buy from Supplier
sars-cov-2 spike protein rbd-coated plates, clear, 96-well  (ACROBiosystems)
N/A
SARS-CoV-2 Spike protein RBD-Coated Plates, Clear, 96-Well
   Buy from Supplier

Image Search Results


CT-P13 quantification of exogenously-spiked samples (μg/ml). The bars indicate the mean concentration obtained with each assay in the different concentrations, and the error bars refer to the standard deviation. IFX, infliximab; QB, Quantum Blue ® Infliximab: Quantitative Lateral Flow Assay (Bühlmann, Schönenbuch, Switzerland).

Journal: Therapeutic Advances in Gastroenterology

Article Title: Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

doi: 10.1177/1756283X17722915

Figure Lengend Snippet: CT-P13 quantification of exogenously-spiked samples (μg/ml). The bars indicate the mean concentration obtained with each assay in the different concentrations, and the error bars refer to the standard deviation. IFX, infliximab; QB, Quantum Blue ® Infliximab: Quantitative Lateral Flow Assay (Bühlmann, Schönenbuch, Switzerland).

Article Snippet: Spiked samples of known CT-P13 concentrations (0.5, 1, 1.5, 3, 5, 7, 10, 15, 20, 30 and 40 μg/ml) were generated by diluting the appropriate amount of exogenous CT-P13 (Remsima ® , Celltrion, South Korea) into a pool of serum from control donors.

Techniques: Concentration Assay, Standard Deviation, Lateral Flow Assay

Cohort characterization.

Journal: Therapeutic Advances in Gastroenterology

Article Title: Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

doi: 10.1177/1756283X17722915

Figure Lengend Snippet: Cohort characterization.

Article Snippet: Spiked samples of known CT-P13 concentrations (0.5, 1, 1.5, 3, 5, 7, 10, 15, 20, 30 and 40 μg/ml) were generated by diluting the appropriate amount of exogenous CT-P13 (Remsima ® , Celltrion, South Korea) into a pool of serum from control donors.

Techniques:

Qualitative comparison between the CT-P13 quantification assays using the therapeutic interval 3–7 µg/ml.

Journal: Therapeutic Advances in Gastroenterology

Article Title: Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

doi: 10.1177/1756283X17722915

Figure Lengend Snippet: Qualitative comparison between the CT-P13 quantification assays using the therapeutic interval 3–7 µg/ml.

Article Snippet: Spiked samples of known CT-P13 concentrations (0.5, 1, 1.5, 3, 5, 7, 10, 15, 20, 30 and 40 μg/ml) were generated by diluting the appropriate amount of exogenous CT-P13 (Remsima ® , Celltrion, South Korea) into a pool of serum from control donors.

Techniques: